DaVita

DVA Mid Cap

Healthcare · Medical Care Facilities

Updated: Apr 5, 2026, 00:03 UTC

$145.58

-3.17% today

52W: $101.00 – $159.42

52W Low: $101.00 Position: 76.3% 52W High: $159.42

🔗 Compare Brokers Best Broker for Beginners →

Key Metrics

P/E Ratio

15.31x

Price-to-Earnings

Forward P/E

8.91x

Forward Price/Earnings

P/S Ratio

0.71x

Price-to-Sales

EV/EBITDA

8.62x

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$9.7B

Market Capitalization

Revenue Growth

9.9%

YoY Revenue Growth

Profit Margin

5.47%

Net profit margin

ROE

64.85%

Return on Equity

Beta

0.92

Market sensitivity

Short Interest

19.17%

% of float sold short

Avg. Volume

1,097,148

Average daily volume

Valuation Analysis

Signal

Undervalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

None

7 analysts

Avg. Price Target

$151.71

+4.21% upside

Target Range

$126.00 – $190.00

🚫 Not currently held by any of our 15 tracked Smart Money managers. View Smart Money Tracker →

About the Company

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engage

Sector: Healthcare Industry: Medical Care Facilities Country: United States Employees: 78,000 Exchange: NYQ